Skip to main content

Table 1 Global incidence, mortality and DALYs of genitourinary cancers from 1990 to 2019

From: Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019

 

Kidney cancer

Bladder cancer

Prostate cancer

Both

Male

Female

Both

Male

Female

Male

1990*

       

Incident cases (× 103)

145.91

(140.80–150.33)

86.06

(82.70–89.44)

59.85

(57.39–62.13)

234.75

(225.46–243.08)

177.76

(170.77–184.13)

56.99

(53.45–60.31)

524.11

(409.13–613.01)

Deaths (× 103)

72.10

(68.88–74.67)

43.46

(41.33–45.51)

28.64

(27.24–29.66)

121.50

(114.75–127.17)

88.12

(83.47–91.86)

33.38

(30.66–35.84)

233.00

(191.40–268.88)

DALYs (× 103)

2039.40

(1943.70–2144.10)

1260.71

(1189.84–1349.99)

778.69

(738.21–829.72)

2567.06

(2429.47–2691.11)

1901.45

(1798.60–1987.27)

665.60

(613.69–722.30)

4360.51

(3528.03–4951.01)

ASIR (1/105)

3.53

(3.40–3.63)

4.51

(4.34–4.67)

2.70

(2.59–2.80)

6.27

(5.98–6.50)

10.94

(10.43–11.34)

2.77

(2.59–2.93)

34.13

(26.83–39.65)

ASMR (1/105)

1.86

(1.77–1.93)

2.50

(2.37–2.60)

1.36

(1.28–1.41)

3.49

(3.27–3.66)

6.13

(5.77–6.41)

1.70

(1.54–1.82)

18.13

(14.68–21.19)

ASDR (1/105)

47.28

(45.22–49.37)

61.96

(58.81–65.46)

34.30

(32.65–36.08)

66.59

(63.00–69.73)

111.68

(105.56–116.61)

31.66

(29.19–34.29)

286.30

(232.78–326.21)

2019*

       

Incident cases (× 103)

371.75

(344.59–402.35)

240.54

(220.79–261.82)

131.21

(119.71–142.42)

524.30

(475.95–569.43)

407.87

(371.30–443.75)

116.44

(103.71–128.21)

1410.45

(1227.90–1825.77)

Deaths (× 103)

166.44

(155.46–176.3)

108.77

(101.48–115.82)

57.67

(52.24–61.90)

228.73

(210.74–243.19)

169.21

(156.92–180.66)

59.53

(52.33–64.58)

486.84

(420.5–593.69)

DALYs (× 103)

4052.82

(3801.04–4317.49)

2735.71

(2544.82–2931.33)

1317.11

(1228.35–1413.53)

4392.58

(4090.44–4702.73)

3326.50

(3093.91–3570.17)

1066.08

(962.71–1150.12)

8644.87

(7548.02–10,559.87)

ASIR (1/105)

4.55

(4.22–4.93)

6.24

(5.74–6.79)

3.07

(2.80–3.33)

6.52

(5.93–7.09)

11.28

(10.23–12.27)

2.66

(2.37–2.93)

38.63

(33.63–49.83)

ASMR (1/105)

2.08

(1.93–2.20)

2.99

(2.78–3.18)

1.33

(1.20–1.42)

2.94

(2.70–3.13)

5.09

(4.69–5.44)

1.36

(1.19–1.47)

15.28

(13.00–18.57)

ASDR (1/105)

49.62

(46.46–52.94)

70.06

(65.14–75.07)

31.08

(28.95–33.38)

54.20

(50.35–57.97)

90.17

(83.63–96.61)

24.43

(22.10–26.35)

244.07

(211.78–297.72)

1990–2019

       

ASIR

       

EAPC (95% CI)

0.87

(0.76–0.99)

1.13

(1.01–1.26)

0.39

(0.30–0.49)

0.07

(0.04–0.10)

0.06

(0.03–0.08)

− 0.24

(− 0.29 to − 0.18)

0.26

(0.15–0.37)

ASMR

       

EAPC (95% CI)

0.35

(0.26–0.45)

0.61

(0.51–0.70)

− 0.13

(− 0.20 to − 0.05)

− 0.68

(− 0.71 to − 0.65)

− 0.71

(− 0.73 to − 0.68)

− 0.89

(− 0.94 to − 0.84)

− 0.75

(− 0.84 to − 0.67)

ASDR

       

EAPC (95% CI)

0.12

(0.04–0.20)

0.40

(0.30–0.49)

− 0.41

(− 0.46 to − 0.36)

− 0.83

(− 0.86 to − 0.79)

− 0.84

(− 0.87 to − 0.81)

− 1.04

(− 1.08 to − 0.99)

− 0.71

(− 0.78 to − 0.64)

  1. DALYs disability-adjusted life-years, ASIR age-standardized incidence rate, ASMR age-standardized mortality rate, ASDR age-standardized DALYs rate; EAPC estimated annual percentage change, CI confidence interval
  2. *All data reported as number or rate (95% uncertainty interval)